Ruthenium Based Protein Protein Interaction Inhibitor s
In this research, the fellow (Jayapal Reddy Mallareddy) will synthesize novel cell permeable fluorescent ruthenium complexes and demonstrate their utility for perturbing biological processes. This fellowship will build on the fell...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
MET-EFFECT
Metal complexes of a naturally inspired framework functional...
764K€
Cerrado
PHOTORUACD
Novel Photodissociable Ruthenium Based Anticancer Drugs
178K€
Cerrado
OrganometRuPDT
Cancer Cell Specific Organometallic Ru II Complexes as Phot...
108K€
Cerrado
DINURU
The Synthesis and Evaluation of Organometallic Dinuclear Rut...
179K€
Cerrado
RUPROLIGHT
Light activatable ruthenium based anticancer prodrugs
1M€
Cerrado
UNIVERSITY OF LEEDS
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
222K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
In this research, the fellow (Jayapal Reddy Mallareddy) will synthesize novel cell permeable fluorescent ruthenium complexes and demonstrate their utility for perturbing biological processes. This fellowship will build on the fellows expertise in synthetic chemistry (particularly peptide synthesis) applied at the biological interface, together with Leeds’ expertise in the design and synthesis of cell permeable inhibitors of protein-protein interactions. The project will ultimately furnish cell permeable fluorescent small molecules designed to act as inhibitors of key protein-protein interactions involved in disease development and progression. Such inhibitors can be used as tool molecules to understand biological processes, as sensors for malfunctioning proteins and as the starting point for development of new molecular therapeutics thus impacting the competitiveness of the EU, and the quality of life of its citizens, by facilitating new strategies for diagnosing and treating disease.